Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix
Extracellular matrix (ECM) deposition is a hallmark of many diseases, including cancer and fibroses. To exploit the ECM as an imaging and therapeutic target, we developed alpaca-derived libraries of “nanobodies” against disease-associated ECM proteins. We describe here one such nanobody, NJB2, speci...
Main Authors: | Jailkhani, Noor, Ingram, Jessica R., Rashidian, Mohammad, Rickelt, Steffen, Tian, Chenxi, Mak, Howard, Jiang, Zhigang, Ploegh, Hidde L., Hynes, Richard O |
---|---|
Other Authors: | Koch Institute for Integrative Cancer Research at MIT |
Format: | Article |
Language: | English |
Published: |
National Academy of Sciences
2020
|
Online Access: | https://hdl.handle.net/1721.1/126031 |
Similar Items
-
Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice
by: Xie, Yushu Joy, et al.
Published: (2020) -
Antibodies and methods for immunohistochemistry of extracellular matrix proteins
by: Rickelt, Steffen, et al.
Published: (2020) -
Nanobodies as non-invasive imaging tools
by: M. Rashidian, et al.
Published: (2020-09-01) -
Exploring cellular biochemistry with nanobodies
by: Cheloha, Ross W, et al.
Published: (2021) -
A nanobody suite for yeast scaffold nucleoporins provides details of the nuclear pore complex structure
by: Nordeen, Sarah A., et al.
Published: (2022)